EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?

Martijn van Dorp iD, Constantia Trimbos, Wilhelmina H Schreurs, Chris Dickhoff, David J Heineman iD, Bart Torensma iD, Geert Kazemier, Frank J C van den Broek iD, Ben J Slotman, Max Dahele

Cancers · 28.10.2023 · 15 (21) · 5186

DOI: 10.3390/cancers15215186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 28.10.2023. Verfasst von Martijn van Dorp und 9 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam University Medical Center, Location VUmc, Department of Cardiothoracic Surgery, 1007 MB Amsterdam, The Netherlands. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary metastasectomy and stereotactic ablative radiotherapy (SABR) are both guideline-recommended treatments for selected patients with oligometastatic colorectal pulmonary metastases. However, there is limited evidence comparing these local treatment modalities in similar patient groups.

Methods

We retrospectively reviewed records of consecutive patients treated for colorectal pulmonary metastases with surgical metastasectomy or SABR from 2012 to 2019 at two Dutch referral hospitals that had different approaches toward the local treatment of colorectal pulmonary metastases, one preferring surgery, the other preferring SABR. Two comparable patient groups were identified based on tumor and treatment characteristics.

Results

The metastasectomy group comprised 40 patients treated for 69 metastases, and the SABR group had 60 patients who were treated for 90 metastases. Median follow-up was 38 months (IQR: 26–67) in the surgery group and 46 months (IQR: 30–79) in the SABR group. Median OS was 58 months (CI: 20–94) in the metastasectomy group and 70 months (CI: 29–111) in the SABR group (p = 0.23). Five-year local recurrence-free survival (LRFS) was 44% after metastasectomy and 30% after SABR (p = 0.16). Median progression-free survival (PFS) was 15 months (CI: 3–26) in the metastasectomy group and 10 months (CI: 6–13) in the SABR group (p = 0.049). Local recurrence rate was 12.5/7.2% of patients/metastases respectively after metastasectomy and 38.3/31.1% after SABR (p < 0.001). Lower BED Gy10 was correlated with an increased likelihood of recurrence (p = 0.025). Clavien Dindo grade III-V complication rates were 2.5% after metastasectomy and 0% after SABR (p = 0.22).

Conclusion

In this retrospective cohort study, pulmonary metastasectomy and SABR had comparable overall survival, local recurrence-free survival, and complication rates, despite patients in the SABR group having a significantly lower progression-free survival and local control rate. These data would support a randomized controlled trial comparing surgery and SABR in operable patients with radically resectable colorectal pulmonary metastases.

Schlagwörter

Stichwörter der Autor:innen

RCTSABRcolorectal lung metastasesoligometastatic colorectal cancerpulmonary metastasectomy

Autor:innen und Institutionen

  • Amsterdam University Medical Center, Location VUmc, Department of Cardiothoracic Surgery, 1007 MB Amsterdam, The Netherlands.
  • Cancer Center Amsterdam, Imaging and Biomarkers, 1081 HV Amsterdam, The Netherlands.
  • Northwest Clinics, Department of Surgery, 1815 JD Alkmaar, The Netherlands.
  • Department of Anesthesiology, Leiden University Medical Centre, 2333 ZA Leiden, The Netherlands.
  • Amsterdam University Medical Center, Location VUmc, Department of Surgery, 1007 MB Amsterdam, The Netherlands.
  • Máxima Medical Centra, Department of Surgery, 5657 EG Veldhoven, The Netherlands.

ORCID-Profile: Martijn van Dorp, David J Heineman, Bart Torensma, Frank J C van den Broek

Zitieren

APA

van Dorp, M., Trimbos, C., Schreurs, W. H., Dickhoff, C., Heineman, D. J., Torensma, B., Kazemier, G., van den Broek, F. J. C., Slotman, B. J., & Dahele, M. (2023). Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?. Cancers, 15(21), 5186. https://doi.org/10.3390/cancers15215186

Vancouver

van Dorp M, Trimbos C, Schreurs WH, Dickhoff C, Heineman DJ, Torensma B, et al. Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?. Cancers. 2023;15(21):5186. doi:10.3390/cancers15215186

BibTeX
@article{vanDorp2023,
  author = {van Dorp, Martijn and Trimbos, Constantia and Schreurs, Wilhelmina H and Dickhoff, Chris and Heineman, David J and Torensma, Bart and Kazemier, Geert and van den Broek, Frank J C and Slotman, Ben J and Dahele, Max},
  title = {Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {21},
  pages = {5186},
  doi = {10.3390/cancers15215186}
}
Kostenlos starten →